Osagie O. Imasogie

Chairman & Chief Executive Officer at Ibere Pharmaceuticals

Osagie O. Imasogie

Osagie O. Imasogie

Chairman & Chief Executive Officer at Ibere Pharmaceuticals

Overview
Career Highlights

Endo Pharmaceuticals, Inc.
DuPont Merck Pharmaceutical Co.
iCeutica Pharmaceuticals, Inc.

RelSci Relationships

2684

Number of Boards

21

Birthday

1962

Age

59

Number of Awards

1

Relationships
RelSci Relationships are individuals Osagie O. Imasogie likely has professional access to. A relationship does not necessarily indicate a personal connection.

Co-Founder at Phoenix IP Ventures LLC

Relationship likelihood: Strong

Co-Founder & Managing Partner at Phoenix IP Ventures LLC

Relationship likelihood: Strong

Chief Executive Officer at Iroko Pharmaceuticals LLC

Relationship likelihood: Strong

President at University of Pennsylvania

Relationship likelihood: Strong

President & Chief Executive Officer at iCeutica Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chief Executive Officer & Executive Chairman at Cozen O'Connor

Relationship likelihood: Strong

Co-Founder at FS Investments

Relationship likelihood: Strong

Vice Chairman at The Philadelphia Orchestra Association

Relationship likelihood: Strong

Founder at Permit Capital LLC

Relationship likelihood: Strong

Former President & Chief Executive Officer at La Salle University

Relationship likelihood: Strong

Paths to Osagie O. Imasogie
Potential Connections via
Relationship Science
You
Osagie O. Imasogie
Chairman & Chief Executive Officer at Ibere Pharmaceuticals
Education
LLM

The University of Pennsylvania Law School, located in Philadelphia, Pennsylvania, is the law school of the University of Pennsylvania. A member of the Ivy League, it is among the oldest and most selective law schools in the nation. It is currently ranked 7th overall by U.S. News & World Report, and 1st in terms of career prospects by the Princeton Review, a rank awarded also by the National Law Journal based on placement of graduates in top law firms.It offers the degrees of Juris Doctor (J.D.), Master of Laws (LL.M.), Master of Comparative Laws (LL.C.M.), and Doctor of the Science of Law (S.J.D.).

Memberships
Member
Current

The New York State Bar Association (NYSBA) is a voluntary bar association for the state of New York. NYSBA was founded in 1877 with the stated goal to cultivate the science of jurisprudence; to promote reform in the law; to facilitate the administration of justice, and to elevate the standards of integrity, honor, professional skill, and courtesy in the legal profession. Its first President was David B. Hill. Among the reforms in the legislation signed into law creating the association was the removal of the restrictions on the admission of women to the practice of law. In 1896, NYSBA proposed the first global means for settling disputes among nations, what is now called the Permanent Court of Arbitration in The Hague.

Member
Current
Career History
Co-Founder
2004 - Current

Phoenix IP Ventures focuses on investments in the pharmaceutical, biotechnology and financial sectors.

Chairman & Chief Executive Officer
Current

Ibere Pharmaceuticals is a blank check company. It engages in effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The company was founded on October 22, 2020 and is headquartered in Philadelphia, PA.

Principal
Current

Quoin Capital LLC engages in the provision of brokerage and investment management services. It specializes in public finance, equity and fixed income trading, and market commentary. It offers global trade, alternative assets, venture capital, and mergers and acquisitions. The company was founded by Maceo N. Davis in 2005 and is headquartered in Philadelphia, PA.

Boards & Committees
Member, Board of Directors
2004 - 2009

Genaera Corp. develops drugs for asthma, cancer, cystic fibrosis and age-related macular degeneration. It is a biopharmaceutical company committed to developing medicines for serious diseases from genomics and natural products. It's products include EVIZON, to treat ophthalmic indications, specifically age-related macular degeneration. Squalamine lactate, for the treatment of cancerous solid tumors. It's third product candidate, LOMUCIN to treat the overproduction of mucus secretions involved in chronic respiratory disease. Fourth product candidate, interleukin-9 antibody, is a respiratory treatment based on the discovery of a genetic cause of asthma. It also has a number of discovery research programs focused on the treatment of obesity, infectious diseases and inflammatory disorders. The company is headquartered in Plymouth Meeting, PA.

Chairman
2004 - 2007

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

Chairman, Board of Trustees
2000 - 2005

TO MAINTAIN A DIVERSE AND WELCOMING COMMUNITY FOR SCHOLARS FROM AROUND THE WORLD, WHILE INTRODUCING THEM TO THE AMERICAN EXPERIENCE; SOURCE OF DISTINCTIVE PROGRAMMING.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1,000 - $4,999
2019

TRANSFORMING LIVES THROUGH THE POWER OF DIVERSITY IN THE ARTS.

$100K - $250K
2018

The Philadelphia Museum of Art operates as a not-for-profit organization and supported by endowments, voluntary gifts, corporate support, private foundation grants, and state and federal grants, as well as from admissions, membership fees, and merchandise sales. The firm is showcasing human creativity in painting, sculpture, and works on paper, decorative arts and architectural settings from Asia, Europe, and Latin America. The company was founded in 1874 and is headquartered in Philadelphia, PA.

$500 +
2018

The Barnes Foundation is a non-profit organization, which engages in promoting the advancement of education and appreciation of fine art and horticulture. It also provides facilities for educational programs as well as special exhibitions and visitor amenities. The company was founded by Albert Coombs Barnes in 1922 and is headquartered in Philadelphia, PA.

Political Donations
$500
2012

Executive Director Through Feb at The Birth Center

$1,000
2012

DNC Service Corp. operates a political party. It is an organization which raises fund for the Democratic Party which has been a part of the U.S. political landscape. The company plans the presidential nominating convention, promotes candidates from the local to the national level and sets the party platform. DNC Service was founded in 1848 and is located in Washington, DC.

$500
2012

President & Chief Executive Officer at Better Medicare Alliance

Investments
Details Hidden

iCeutica, Inc. manufactures pharmaceutical products. It offers SoluMatrix platform, a drug reformulation and delivery technology for poorly water-soluble compounds. This technology enables iCeutica to make significantly improved formulations of approved and development stage drugs, some of which have been shown in late stage clinical trials to work faster, at a lower dose or be delivered to the body by an alternative route. The company was founded by James Williams and Matthew Callahan in 2005 and is headquartered in Philadelphia, PA.

Details Hidden

Ception Therapeutics, Inc. Develops pharmaceutical products. It focuses on the discovery and development of novel products to address areas of unmet medical need. The company was founded in 2004 and is headquartered in Malvern, PA.

Public Holdings
Restricted data only for RelSci Professional users.
Awards & Honors
University of Pennsylvania, School of Dental Medicine - Alumni Award of Merit
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Osagie O. Imasogie. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Osagie O. Imasogie's profile does not indicate a business or promotional relationship of any kind between RelSci and Osagie O. Imasogie.